Stock Events

Stock Events

ImmuneOnco Biopharmaceuticals (Shanghai) (1541.HK) Q3 2026 Earnings

1SepConfirmed

Q1 2025

Q3 2025

Q1 2026

-0.4

-0.07

0.26

0.6

Details

Expected EPS

N/A

Actual EPS

N/A

Surprise EPS

0

Surprise Percent

+NaN%

Description

ImmuneOnco Biopharmaceuticals (Shanghai) (1541.HK) will report earnings of for Q3 2026 on September 01, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.